Application

18033100 · INTERLEUKIN-17 INHIBITORS

Filed 2023-04-21 · Granted · Patent 12600728 (2026-04-14) The official file ↗The patent and its PDF ↗ · Art unit 1622 · Examiner Manahil Mirghani Ali Abdalhameed Typical · CPC C07D 401/12 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

27.7 mo

to disposition 35.8 mo

Statutes raised

102 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.